Zoloft and Birth Defects
Studies published by the New England Journal of Medicine (NEJM) have found that Zoloft users are more likely to give birth to a child with congenital heart defects or other birth defects than non-users. Multiple warnings from the Food and Drug Administration have cautioned about the use of Zoloft during pregnancy because of the increased risk of serious birth defects the drug may cause.
The increased risk of heart defects associated with Zoloft can occur no matter whether the drug is used during the early or later stages of pregnancy. When taken during the first trimester, Zoloft users may be more likely to give birth to a child with ventricular outflow tract obstruction defects, hypoplastic left heart syndrome (HLHS), ventricular septal defects (VSD) or atrial septal defects (ASD). Women who use Zoloft during the third trimester may increase their risk of giving birth to a child with persistent pulmonary hypertension of the newborn (PPHN).
Regardless of when it is taken during pregnancy, Zoloft may also increase the risk of a number of other heart defects, including Tetralogy of Fallot, transposition of the great arteries, coarctation of the aorta, cardiomyopathy, anencephaly, patent ductus arteriosus (PDA), tricuspid stenosis, cleft mitral valve or bicuspid aortic valve. Research published by the NEJM has also linked Zoloft with an increased risk of craniosynostosis and omphalocele.
Women who used Zoloft during pregnancy and gave birth to a child with heart defects or other congenital birth defects may be eligible to file a lawsuit and receive compensation. The first step in finding out whether you qualify for a lawsuit is to speak with a qualified Zoloft lawyer about your situation.
To receive a free legal consultation about Zoloft from an attorney, contact the law firm of Hissey Kientz, LLP. You can reach us by calling toll-free at 1-866-275-4454, or by filling out the free case evaluation form located on this page.